Addition of Raltegravir to Established Antiretroviral Suppressive Therapy

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2010 by University of Miami.
Recruitment status was  Not yet recruiting
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by:
University of Miami
ClinicalTrials.gov Identifier:
NCT01245101
First received: November 19, 2010
Last updated: NA
Last verified: November 2010
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: June 2012
  Estimated Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)